Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Buy
4,931
+541
+12% +$28.6K ﹤0.01% 581
2026
Q1
$242K Buy
4,390
+140
+3% +$7.59K ﹤0.01% 577
2025
Q4
$208K Buy
+4,250
New +$198K ﹤0.01% 618

Other funds holding GSK

Modera Wealth Management's GSK Position: Q2 2026 in Review

Modera Wealth Management increased its GSK (GSK) stake by 12% in Q2 2026, buying an estimated $28.6K and bringing the position to 4,931 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Modera Wealth Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Modera Wealth Management held 4,931 shares of GSK worth $258K as of Q2 2026.
  • Modera Wealth Management bought 541 GSK shares in Q2 2026, an estimated $28.6K.
  • GSK made up ﹤0.01% of Modera Wealth Management's portfolio in Q2 2026, its #581 holding.
  • Modera Wealth Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Modera Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.